HIGHLIGHTS
- who: Inhibiting IL- and colleagues from the The Affiliated Stomatological Hospital of Southwest Medical University, Jiangyang Nan Road, Luzhou, China have published the paper: A GP130-Targeting Small Molecule, LMT-28, Reduces LPS- Induced Bone Resorption around Implants in Diabetic Models by Inhibiting IL-6/GP130/JAK2/STAT3 Signaling, in the Journal: Mediators of Inflammation of 11/09/2022
- what: The authors examined the effect of the GP130-targeting molecule LMT-28 on lipopolysaccharide- (LPS-) induced bone resorption around implants in diabetic models using in vitro and rat animal experiments. The authors demonstrated that LMT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.